Progress of Gene-Modified Hematopoietic Stem Cell Therapy For Hemoglobinopathies

Progress of Gene-Modified Hematopoietic Stem Cell Therapy For Hemoglobinopathies

Sickle cell disease and β-thalassemia represent the most common forms of hemoglobinopathies. Since the first successful bone marrow transplant in 1981, hematopoietic stem cell transplantation is the only treatment option for the patients. However, the current routine therapies for these con...

Full description

Bibliographic Details
Main Authors: Atil Bisgin, Ibrahim Ethem Ay, Gulay Sezgin
Format: Article
Language:Turkish
Published: Cukurova University Faculty of Medicine 2014-02-01
Series:Arsiv Kaynak Tarama Dergisi
Subjects:
Hemoglobinopathy
Gene Therapy
Stem Cell Therapy
iPS with Homolog Recombination
Chimeraplasty
Online Access:http://www.scopemed.org/fulltextpdf.php?mno=43661

Internet

http://www.scopemed.org/fulltextpdf.php?mno=43661

Similar Items